TNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

TNGX stock results show that Tango Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

The post TNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q4 2023 appeared first on InvestorPlace.

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• “America’s Top Trader” Issues A.I. Code Red: Act Now or Miss Out
• It doesn’t matter if you have $500 or $5 million. Do this now.